Stay Informed

Featured Articles

Albert Bourla Reflects on the One Year Anniversary of the COVID-19 Pandemic (April 2021)

Annual Review Highlights a Historic Year (April 2021)

Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2 (April 2021)

Biosimilars: Advancing Science to Help Improve Patient Access to Medicines (April 2021)

Real-world Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared (April 2021)

Global Survey Results: Cancer & Aging (March 2021)

Setting the Stage for a Fight: Enlisting T-cells to Combat Multiple Myeloma (March 2021)

The Potential of Antivirals (March 2021)

From Outbreak to Immunity (March 2021)

Pfizer Initiates Pivotal Phase 2 Magnetismm-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab (PF-06863135) in Multiple Myeloma (March 2021)

Pfizer and Biontech Submit COVID-19 Vaccine Stability Data at Standard Freeze Temperature to the U.S. FDA (March 2021)

The Facts About Pfizer and BioNTech's COVID-19 Vaccine (February 2021)

How do Viruses Make us Sick? (February 2021)

Albert Bourla on Ensuring Equitable Access to COVID-19 Vaccines (January 2021)

A New Pfizer (January 2021)

Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19 (December 2020)

Working to Develop a More Safe and Convenient Treatment Option for Patients with Rare Platelet Disorder (December 2020)

Cancer Doesn't Wait: Why People Need to Get Back to Cancer Screenings and Follow-up Appointments (December 2020)

COVID-19 Vaccine Development (November 2020)

Albert Bourla Discusses COVID-19 Vaccine Efficacy Results (November 2020)

Coronavirus and Immunity: Key Questions as Society Begins to Reopen (October 2020)

Empowering People with 'Super Genes' to Help Unlock New Treatment Pathways (October 2020)

The Antigen Podcast Season 2 (August 2020)

New Pathways to Cachexia Treatment: Focusing on Patient Quality of Life (August 2020)

Age: Addressing a Blind Spot in Cancer Care (July 2020)

The 14-Day Quarantine: Understanding the Coronavirus Incubation Period (July 2020)

The Antigen Podcast Season 2 (June 2020)

Uncovering New Biomarkers to Better Understand Friedreich’s Ataxia (June 2020)

Sweet Science: How Insights into Fructose Metabolism Are Helping to Fight Liver Disease (June 2020)

What Makes an RNA Vaccine Different From a Conventional Vaccine? (May 2020)

AI in Drug Safety: Building the Elusive ‘Loch Ness Monster’ of Reporting Tools (May 2020)

Joining Forces to Share Data to Fight COVID-19 (May 2020)

BioNTech and Pfizer Announce Regulatory Approval from German Authority Paul-Ehrlich-Institut to Commence First Clinical Trial of COVID-19 Vaccine Candidates (April 2020)

4 Things to Know About the Science of Coronavirus (April 2020)

All Hands on Deck as Scientists Revive SARS Protease Inhibitor to Attempt to Fight COVID-19 (April 2020)

Managing Your Mental Health During a Pandemic (April 2020)

Pfizer Outlines Five-Point Plan to Battle COVID-19 (March 2020)

Pfizer & BioNTech to Co-Develop Potential COVID-19 Vaccine (March 2020)

Racing to Develop a Potential COVID-19 Vaccine with Unprecedented Partnership (March 2020)

Get Science Podcast: The Next Generation of Scientists Learn the Ropes of the Industry (February 2020)

The Rise of RNA: The Cellular Workhorse Behind a New Class of Next-Gen Therapies (February 2020)

Taking a New Tack for Next-Generation IBD Treatments (February 2020)

In Conversation with the Data Hippie: Using Real World Evidence for Better Medicines (January 2020)

The Future of Flu Season: How RNA Technology Could Revolutionize Vaccine Production (January 2020)

Breakthroughs that Change Patients’ Lives (January 2020)